Egypt’s Drug Authority (EDA) has published six commercial fraud circulars covering packs of unknown source and unregistered products, including capsules bearing the details of Pfizer’s Ibrance.
Pharmacies, distributors and wholesalers should check stock against the details below. In three cases the circular identifies specific batch numbers of a product. In the other three the circular covers all batches, because the product as described is not registered with the EDA.
Packs reported as not belonging to the named company
| Product | Batch | Company | Stated basis |
|---|---|---|---|
| Ibrance (palbociclib) 125mg capsules | FS5173 | Pfizer, named on pack as manufacturer | Pfizer informed the EDA that packs bearing the stated details do not belong to it and were not manufactured with its knowledge, making them of unknown source |
| Cialis 20mg | D877734, D872150, D899702 | Akhnaton for Trade and Distribution, the product’s agent in Egypt | The importer reported the existence of imitation packs of the product |
| Notussil oral suspension 120ml | 243060A | Chemipharm for Pharmaceutical Industries, named on pack as manufacturer | Chemipharm informed the EDA that packs with the differences described do not belong to it and were not produced or manufactured with its knowledge |
Products stated to be unregistered
| Product | Batches | Details on pack |
|---|---|---|
| EXO Shower Gel with Ketoconazole, Anti Fungal & Bacterial Shower Gel | All batches | Registration number on pack 64652/2021; manufacturer named on pack as Aveta for Newgen |
| Clear Up Gel with Benzoyl Peroxide 1.35 fl oz / 75g | All batches | Manufacturer named on pack as Newgen Pharmaceuticals, produced by E.C.C for Newgen Pharmaceuticals |
| Lipotropic Magnum | All batches to date | No manufacturer recorded on packs; registration number on pack given as 62146/2020 in English and 12146/2020 in Arabic |
For the EXO and Clear Up gels, the EDA said its cosmetic preparations registration administration reported that the product with the stated details is not registered and not listed in the authority’s database. For Lipotropic Magnum, the central administration for registration of cosmetic preparations reported that the product with the stated details is not registered in the EDA database and is not authorised for circulation.
In each of the six circulars the EDA ordered the seizure and quarantine of packs not conforming to specifications, directed anyone in doubt about a product to the authority’s 15301 hotline or its website, and provided a link to images of the affected packs. Each circular states that it applies only to the batches it names and not to circulation of the product generally.
Sources: Egyptian Drug Authority commercial fraud circulars, October 2026, published on the authority’s website on 28 October 2026 —
Lipotropic Magnum (2283): https://www.edaegypt.gov.eg/media/yvpn2nie/2283-غش-تجاري-lipotropic.pdf
Cialis 20mg (2287): https://www.edaegypt.gov.eg/media/vrbbn30f/2287-cialis.pdf
Ibrance 125mg (2288): https://www.edaegypt.gov.eg/media/5nejxgmw/2288-ibrance-نشر.pdf
Notussil 120ml (2308): https://www.edaegypt.gov.eg/media/yq0b03hc/2308-notussil.pdf
EXO Shower Gel (2309): https://www.edaegypt.gov.eg/media/jindlrdj/2309-exo-shower-gel.pdf
Clear Up Gel (2310): https://www.edaegypt.gov.eg/media/jengd3cs/2310-clear-up-gel.pdf
